BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2731568)

  • 21. [Myasthenia gravis: epidemiology and prognosis].
    Murai H
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():472-6. PubMed ID: 26480744
    [No Abstract]   [Full Text] [Related]  

  • 22. The Epidemiology of Myasthenia Gravis in Korea.
    Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
    Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myasthenia gravis on the Dutch antilles: an epidemiological study.
    Holtsema H; Mourik J; Rico RE; Falconi JR; Kuks JB; Oosterhuis HJ
    Clin Neurol Neurosurg; 2000 Dec; 102(4):195-198. PubMed ID: 11154803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients.
    Szobor A
    Acta Med Hung; 1989; 46(1):13-21. PubMed ID: 2771581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nationwide epidemiological study of myasthenia gravis in Latvia.
    Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V
    Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of myasthenia gravis among rural adult populations.
    Nemet AY; Kaiserman I; Mimouni M; Segal O; Vinker S
    J Clin Neuromuscul Dis; 2014 Dec; 16(2):47-50. PubMed ID: 25415514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of myasthenia gravis in northwestern Sardinia.
    Aiello I; Pastorino M; Sotgiu S; Pirastru MI; Sau GF; Sanna G; Rosati G
    Neuroepidemiology; 1997; 16(4):199-206. PubMed ID: 9267837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of myasthenia gravis in Norway.
    Storm-Mathisen A
    Acta Neurol Scand; 1984 Oct; 70(4):274-84. PubMed ID: 6507037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996.
    Zivadinov R; Jurjevic A; Willheim K; Cazzato G; Zorzon M
    Neuroepidemiology; 1998; 17(5):265-72. PubMed ID: 9705586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.
    Pallaver F; Riviera AP; Piffer S; Ricciardi R; Roni R; Orrico D; Bonifati DM
    Neuroepidemiology; 2011; 36(4):282-7. PubMed ID: 21757957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis in Sri Lanka.
    Peiris JB; Gunatilake S; Wijeratne C; Gunatillake N
    Ceylon Med J; 1991 Dec; 36(4):155-8. PubMed ID: 1807843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia gravis--a clinical survey in Malaysia.
    Tan CT; Loh TG
    Med J Malaysia; 1980 Dec; 35(2):144-9. PubMed ID: 7266408
    [No Abstract]   [Full Text] [Related]  

  • 33. Geographical distribution of a seropositive myasthenia gravis population.
    Heldal AT; Eide GE; Gilhus NE; Romi F
    Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myasthenia gravis: a clinical observation on 113 cases].
    Matsunaga M; Araki S
    Naika; 1971 Apr; 27(4):742-7. PubMed ID: 5553513
    [No Abstract]   [Full Text] [Related]  

  • 35. Myasthenia gravis at the University of Michigan Medical Center.
    DeJong RN
    Shinkei Kenkyu No Shimpo; 1970; 14(3):463-70. PubMed ID: 5531596
    [No Abstract]   [Full Text] [Related]  

  • 36. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.
    Cetin H; Fülöp G; Zach H; Auff E; Zimprich F
    Wien Klin Wochenschr; 2012 Nov; 124(21-22):763-8. PubMed ID: 23129486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden.
    Kalb B; Matell G; Pirskanen R; Lambe M
    Neuroepidemiology; 2002; 21(5):221-5. PubMed ID: 12207149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
    J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Japanese clinical statistical data of patients with myasthenia gravis].
    Ide Y; Takamori M
    Nihon Rinsho; 1992 Nov; 50 Suppl():186-93. PubMed ID: 1344348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.